Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113. Part III: Pharmacokinetics, metabolism, dose dependency and gender effect after single or repeated administration to human healthy volunteers.

Abstract

A new anti-allergic drug, BM 113 (1-(benzhydryloxyethyl)piperidino-4- ethylacetate, CAS 115313-90-1; BM 113 maleate: CAS 115313-91-2), with a piperidinic structure, showing anti-histaminic properties was studied after administration to healthy human volunteers. The focus was on the pharmacokinetics, the metabolism, the dose dependency and gender differences… (More)

Topics

Cite this paper

@article{Duchne1999PharmacokineticsMA, title={Pharmacokinetics, metabolism and bioavailability of the new anti-allergic drug BM 113. Part III: Pharmacokinetics, metabolism, dose dependency and gender effect after single or repeated administration to human healthy volunteers.}, author={Patrick Duch{\^e}ne and J P Laneury and Gary Tran and Philippe Ladure and Romain Ollivier and Andr{\'a}s Buz{\'a}s and J Y M{\'e}rour and Georges Houin}, journal={Arzneimittel-Forschung}, year={1999}, volume={49 8}, pages={699-704} }